The Hs Management Partners Llc holds 4.91 million shares with $289.77 million value, up from 3.95 million last quarter. Johnson & Johnson now has $377.70 billion valuation. The company reported $1.90 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.80 by $0.10. About 6.07 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since December 9, 2016 and is uptrending. It has underperformed by 25.94% the S&P500. Cowen reissued an "outperform" rating and set a $155.00 price objective (up from $147.00) on shares of Johnson & Johnson in a research report on Wednesday, October 18th. Therefore 57% are positive. Johnson & Johnson's revenue was up 10.3% on a year-over-year basis. research analysts anticipate that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year. The company was maintained on Thursday, August 31 by UBS. As per Thursday, August 4, the company rating was maintained by Jefferies. They issued a "neutral" rating and a $140.00 target price for the company. BMO Capital Markets has "Buy" rating and $145.0 target. Leerink Swann maintained the shares of JNJ in report on Wednesday, October 18 with "Buy" rating. Johnson & Johnson presently has a consensus rating of "Hold" and a consensus price target of $130.90. Piper Jaffray reinitiated it with "Neutral" rating and $105.0 target in Monday, October 5 report. Tiaa Cref Investment Lc reported 172,630 shares or 0% of all its holdings. The stock decreased 0.74% or $1.05 during the last trading session, reaching $140.01. The company had a trading volume of 4,400,500 shares, compared to its average volume of 5,865,332. S&P Research maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, October 14. It has underperformed by 4.16% the S&P500.
Investors sentiment decreased to 0.83 in 2017 Q2. Its down 0.26, from 1.41 in 2017Q1. It fall, as 90 investors sold F shares while 355 reduced holdings. 105 funds opened positions while 667 raised stakes. Tower Bridge invested in 0% or 200,448 shares. Corp Va, Virginia-based fund reported 7,257 shares.
Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, October 17th. Old Dominion Management holds 0.83% in Johnson & Johnson (NYSE:JNJ) or 5,983 shares. 165 are held by Botty Limited. Bnp Paribas Arbitrage Sa stated it has 5.79 million shares. Beacon Advisors Incorporated has invested 0.91% in Johnson & Johnson (NYSE:JNJ). Karpas Strategies Ltd Liability Com stated it has 138,970 shares or 8.29% of all its holdings. Plante Moran Financial Lc holds 18,000 shares. Ifrah Fincl Services stated it has 0.2% in Johnson & Johnson (NYSE:JNJ). Regions Fin Corporation holds 573,474 shares. (NASDAQ:Staten Island, NY). Louisiana State Employees Retirement accumulated 18,500 shares or 0.02% of the stock. Bowen Hanes & Co Inc sold 2,543 shares as Johnson & Johnson (JNJ)'s stock rose 6.85%. The stock has a market capitalization of $378,960.50, a PE ratio of 19.76, a price-to-earnings-growth ratio of 2.87 and a beta of 0.80. It operates through three divisions: Facilities Management, Property Management, and Healthcare. It has a 68.28 P/E ratio. The Consumer segment offers baby care products under the JOHNSONÂ'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONÂ'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.
Bowen Hanes & Co Inc increased Orion Engineered Carbons (Lu) (NYSE:OEC) stake by 390,500 shares to 658,605 valued at $13.14 million in 2017Q2. The institutional investor owned 8,680,532 shares of the company's stock after selling 2,311,470 shares during the period.
West Brom lacked quality against Swansea - Alan Pardew
The Swansea boss said before West Brom's visit that his future did not rest on the outcome of this game. This was Alan Pardew's second game as West Brom boss since succeeding Tony Pulis.
Investors sentiment decreased to 1.15 in 2017 Q2. Its up 1.51, from 1.6 in 2017Q1. Van Strum & Towne invested in 46,228 shares. 76 funds opened positions while 292 raised stakes. Flossbach Von Storch Ag reported 1.30M shares or 1.96% of all its holdings. Gemmer Asset Mgmt Limited Liability Com invested in 10,246 shares or 0.57% of the stock. Sva Plumb Wealth Limited Liability Company owns 78,826 shares for 0.11% of their portfolio.
Hutchin Hill Capital Lp increased Rpx Corp (RPXC) stake by 345.74% reported in 2017Q2 SEC filing. Waddell & Reed Fin holds 0.03% or 104,551 shares in its portfolio. Barclays Public Ltd Co stated it has 0% of its portfolio in Northfield Bancorp, Inc. (NYSE:NKE) for 300 shares. Mechanics Commercial Bank Trust Department has 2.84% invested in Johnson & Johnson (NYSE:JNJ). Tiaa Cref Invest Mgmt Limited Liability invested in 15.06M shares. Jacobson And Schmitt Advsrs Ltd Com reported 110,707 shares. (NASDAQ:Staten Island, NY) for 5,539 shares. Moreover, Connors Investor Services Inc has 0.34% invested in the company for 108,907 shares. (NYSE:NKE). Polen Capital Mngmt Limited Liability Com reported 12.16 million shares or 6.27% of all its holdings. Bb&T owns 725,366 shares or 1.39% of their U.S. portfolio.
Summit Financial Wealth Advisors Llc decreased Ford Mtr Co Del (F) stake by 88.54% reported in 2017Q2 SEC filing.
Analysts await CryoLife, Inc. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Friday, September 22 with "Buy" rating.